Feminine vulval/vaginal practices and normal flora (VVNF)

  • Research type

    Research Study

  • Full title

    Vulval/vaginal practices and their impact on normal flora (VVNF)

  • IRAS ID

    336576

  • Contact name

    Penelope Thomas

  • Contact email

    penelopethomas@nhs.net

  • Sponsor organisation

    WALSALL HEALTHCARE NHS TRUST

  • Clinicaltrials.gov Identifier

    336576, IRAS

  • Duration of Study in the UK

    1 years, 10 months, 0 days

  • Research summary

    This study seeks to explore the range of practices and products employed for feminine hygiene purposes and their possible impact on the vaginal microbiome.

    In the United Kingdom (UK), as in many other other first-world countries, the array of products and existing practices are based on the assumption that feminine hygiene products (FHP) are harmless. However, compared to exposed skin surfaces, vaginal and vulval tissues are more permeable to chemicals.

    A healthy vagina is dominated by bacteria called Lactobacillus (VLB), a first line defence against invading pathogens, including aerobic and anaerobic bacteria, viruses, fungi, protozoa, and reduces the risk from ascending organisms which may have a negative impact on fertility.

    That defence reduces the risk of sexually transmitted infections (STIs), acquisition and transmission of the Human Immunodeficiency Virus (HIV), recurrent thrush and urinary tract infections, as well as bacterial vaginosis (BV).

    The vaginal microbiota in the birth canal are also the keystone to an infant's developing immune system.

    This Study will be conducted by Walsall integrated Sexual Health (WiSH) in the Sexual Health department. The participants will be women or girls identified as female at birth (AFAB), aged 16 years to 55 years, attending for the contraceptive coil.
    Following consent, participants will be asked to fill in a questionnaire and take an additional 'self-taken' swab to measure their vaginal pH. During the procedure another swab (painless) will be taken from the vagina and sent to the in-house laboratory for Gram-staining to measure the lactobacilli under a high-powered microscope. The vaginal lactobacilli and pH will be recorded on the questionnaire along with any coincidentally identified current diagnosis.

    It is anticipated that over a one year period we should have a required 498 participants, following approval. It is also anticipated that the study may take a further 6 months to analyse and write up.

  • REC name

    Wales REC 4

  • REC reference

    26/WA/0167

  • Date of REC Opinion

    6 Aug 2026

  • REC opinion

    Further Information Favourable Opinion